Marcel Deckert (M Deckert)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 23

Top Topics

Multiple Myeloma

Acinetobacter Baumannii

Top Venues

Neurology and therapy

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Mikaël Chelli, Jules Descamps, Vincent Lavoué, Christophe Trojani, Michel Azar, Marcel Deckert, Jean-Luc Raynier, Gilles Clowez, Pascal Boileau, Caroline Ruetsch
Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews: Comparative Analysis. Journal of medical Internet research 26 (2024)
Mikaël Chelli, Jules Descamps, Vincent Lavoué, Christophe Trojani, Michel Azar, Marcel Deckert, Jean-Luc Raynier, Gilles Clowez, Pascal Boileau, Caroline Ruetsch
Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews: Comparative Analysis. Journal of medical Internet research 26 (2024)
Mikaël Chelli, Jules Descamps, Vincent Lavoué, Christophe Trojani, Michel Azar, Marcel Deckert, Jean-Luc Raynier, Gilles Clowez, Pascal Boileau, Caroline Ruetsch
Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews: Comparative Analysis. Journal of medical Internet research 26 (2024)
Mikaël Chelli, Jules Descamps, Vincent Lavoué, Christophe Trojani, Michel Azar, Marcel Deckert, Jean-Luc Raynier, Gilles Clowez, Pascal Boileau, Caroline Ruetsch
Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews: Comparative Analysis. Journal of medical Internet research 26 (2024)
Mikaël Chelli, Jules Descamps, Vincent Lavoué, Christophe Trojani, Michel Azar, Marcel Deckert, Jean-Luc Raynier, Gilles Clowez, Pascal Boileau, Caroline Ruetsch
Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews: Comparative Analysis. Journal of medical Internet research 26 (2024)
Serena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance. Oncogenesis 12 (1) (2023)
Serena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance. Oncogenesis 12 (1) (2023)
Serena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance. Oncogenesis 12 (1) (2023)
Caroline Ruetsch, Darin T Okuda, Fanny Rocher, Sophie Tartare-Deckert, Marcel Deckert, Christine Lebrun-Frénay
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis. Neurology and therapy 12 (1) (2022)
Caroline Ruetsch, Darin T Okuda, Fanny Rocher, Sophie Tartare-Deckert, Marcel Deckert, Christine Lebrun-Frénay
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis. Neurology and therapy 12 (1) (2022)
Caroline Ruetsch, Darin T Okuda, Fanny Rocher, Sophie Tartare-Deckert, Marcel Deckert, Christine Lebrun-Frénay
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis. Neurology and therapy (2022)
Christopher Rovera, Ilona Berestjuk, Margaux Lecacheur, Cassandre Tavernier, Serena Diazzi, Sabrina Pisano, Marie Irondelle, Aude Mallavialle, Jean Albrengues, Cédric Gaggioli, Christophe A Girard, Thierry Passeron, Marcel Deckert, Sophie Tartare-Deckert, Virginie Prod'homme
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells. Cancer research 82 (9) (2022)
Mickael Ohanna, Pierric Biber, Marcel Deckert
Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis. Cancers 14 (14) (2022)
Caroline Ruetsch, Darin T Okuda, Fanny Rocher, Sophie Tartare-Deckert, Marcel Deckert, Christine Lebrun-Frénay
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis. Neurology and therapy 12 (1) (2022)
Caroline Ruetsch, Darin T Okuda, Fanny Rocher, Sophie Tartare-Deckert, Marcel Deckert, Christine Lebrun-Frénay
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis. Neurology and therapy 12 (1) (2022)
Serena Diazzi, Alberto Baeri, Julien Fassy, Margaux Lecacheur, Oskar Marin-Bejar, Christophe A Girard, Lauren Lefevre, Caroline Lacoux, Marie Irondelle, Carine Mounier, Marin Truchi, Marie Couralet, Mickael Ohanna, Alexandrine Carminati, Ilona Berestjuk, Frederic Larbret, David Gilot, Georges Vassaux, Jean-Christophe Marine, Marcel Deckert, Bernard Mari, Sophie Tartare-Deckert
Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma. EMBO molecular medicine 14 (3) (2022)
Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod'homme, Mickael Ohanna, Ana Popovic, Aude Mallavialle, Frédéric Larbret, Sabrina Pisano, Stephane Audebert, Thierry Passeron, Cédric Gaggioli, Christophe A Girard, Marcel Deckert, Sophie Tartare-Deckert
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma. EMBO molecular medicine 14 (2) (2021)
Marion Buffard, Aurélien Naldi, Gilles Freiss, Marcel Deckert, Ovidiu Radulescu, Peter J Coopman, Romain Maxime Larive
Comparison of SYK Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions. Biomolecules 11 (2) (2021)
Christophe A Girard, Margaux Lecacheur, Rania Ben Jouira, Ilona Berestjuk, Serena Diazzi, Virginie Prod'homme, Aude Mallavialle, Frédéric Larbret, Maéva Gesson, Sébastien Schaub, Sabrina Pisano, Stephane Audebert, Bernard Mari, Cédric Gaggioli, Eleonora Leucci, Jean-Christophe Marine, Marcel Deckert, Sophie Tartare-Deckert
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma. Cancer research 80 (10) (2020)
Margaux Lecacheur, Christophe A Girard, Marcel Deckert, Sophie Tartare-Deckert
[Melanoma therapeutic escape: the biomechanical track]. Medecine sciences : M/S 36 (11) (2020)
Serena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies. Cancers 12 (6) (2020)
M Rathore, C Girard, M Ohanna, M Tichet, R Ben Jouira, E Garcia, F Larbret, M Gesson, Stephane Audebert, J-P Lacour, H Montaudié, V Prod'Homme, S Tartare-Deckert, Marcel Deckert
Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway. Oncogene 38 (30) (2019)
Mohamed-Amine Hamouda, Arnaud Jacquel, Guillaume Robert, Alexandre Puissant, Valentine Richez, Romeo Cassel, Nina Fenouille, Sandrine Roulland, Jerome Gilleron, Emmanuel Griessinger, Alix Dubois, Beatrice Bailly-Maitre, Diogo Goncalves, Aude Mallavialle, Pascal Colosetti, Sandrine Marchetti, Martine Amiot, Patricia Gomez-Bougie, Nathalie Rochet, Marcel Deckert, Herve Avet-Loiseau, Paul Hofman, Jean-Michel Karsenti, Pierre-Yves Jeandel, Claudine Blin-Wakkach, Bertrand Nadel, Thomas Cluzeau, Kenneth C Anderson, Jean-Gabriel Fuzibet, Patrick Auberger, Frédéric Luciano
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice. The Journal of experimental medicine 213 (9) (2016)